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Thy-1 is an abundant neuronal glycoprotein of poorly defined function. We recently provided evidence indicating that Thy-1 clusters a β3-
containing integrin in astrocytes to induce tyrosine phosphorylation, RhoA activation and the formation of focal adhesions and stress fibers. To
date, the α subunit partner of β3 integrin in DI TNC1 astrocytes is unknown. Similarly, the ability of neuronal, membrane-bound Thy-1 to trigger
astrocyte signaling via integrin engagement remains speculation. Here, evidence that αv forms an αvβ3 heterodimer in DI TNC1 astrocytes was
obtained. In neuron–astrocyte association assays, the presence of either anti-αv or anti-β3 integrin antibodies reduced cell–cell interaction
demonstrating the requirement of both integrin subunits for this association. Moreover, anti-Thy-1 antibodies blocked stimulation of astrocytes by
neurons but not the binding of these two cell types. Thus, neuron–astrocyte association involved binding between molecular components in
addition to the Thy-1-integrin; however, the signaling events leading to focal adhesion formation in astrocytes depended exclusively on the latter
interaction. Additionally, wild-type (RLD) but not mutated (RLE) Thy-1 was shown to directly interact with αvβ3 integrin by Surface Plasmon
Resonance analysis. This interaction was promoted by divalent cations and was species-independent. Together, these results demonstrate that the
αvβ3 integrin heterodimer interacts directly with Thy-1 present on neuronal cells to stimulate astrocytes.
© 2008 Elsevier B.V. All rights reserved.Keywords: Thy-1; Integrins; Brain cells; Cell–cell interaction; Adhesion molecules1. Introduction
Thy-1 is a 25–37 kDa glycosyl phosphatidyl inositol (GPI)-
anchored protein of the immunoglobulin superfamily expressed
in various cell types, including those of the Tcell lineage, neurons,
a subset of CD34+ blood stem cells, fibroblasts and activated
endothelial cells [1–4]. Thy-1 modulates cell death/proliferation,
signaling, motility and adhesion. Specific examples in the latter
case include Thy-1-induced adhesion of thymocytes to thymic⁎ Corresponding author. Program of Cell and Molecular Biology, Facultad de
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doi:10.1016/j.bbamcr.2008.01.034epithelium, binding of monocytes and polymorphonuclear
leukocytes to Thy-1+ activated endothelial cells and fibroblasts,
activation of lymphocytes and adhesion of Thy-1+ cells to
astrocytes [5–11].
Studies completed by 1992 had shown the GPI-anchored
Thy-1 to be the first lymphocyte surface antigen restricted to a
functional subset of lymphocytes that signalled across the
membrane despite lacking a transmembrane spanning domain.
However, Thy-1 function was not known [12]. A number of
functions have been attributed to Thy-1 and possible mechan-
isms by which this molecule may function are beginning to
emerge [10,13–17], in part due to our discovery identifying aβ3-
containing integrin on astrocytes as a Thy-1 receptor that, upon
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Following this initial finding, Thy-1 expressed on activated
endothelial cells was reported to bind in vitro to the integrins
αvβ3 on melanoma cells [16], as well as αXβ2 and αMβ2 on
leukocytes [15,18]. Taken together, these results identify Thy-1-
integrin interactions as potentially relevant to cell–cell adhesion
events, although the integrin receptor varies depending on the
cells involved.
Our reported data show thatβ3 integrin engagement by Thy-1
leads to integrin clustering, tyrosine phosphorylation of focal
adhesion kinase (FAK) and p130Cas, as well as the activation of
RhoA and p160ROCK. This interaction also induces recruit-
ment of paxillin, vinculin, and FAK to focal contacts, thereby
promoting focal adhesion and stress fiber formation in rat
astrocytes [8,19,20]. These data were obtained by stimulating
astrocytes with either recombinant soluble Thy-1-Fc proteins or
EL-4 thymoma cells which abundantly express Thy-1 at their
surface. Therefore, the relevance of Thy-1/integrin interaction in
neuron–astrocyte communication has never been addressed.
Integrins are heterodimeric transmembrane proteins that
mediate cell-matrix, as well as cell–cell interactions, essential
for adhesion, spreading, migration, and proliferation. Integrins
are formed by the non-covalent association of α and β subunits
and only two heterodimers have been identified containing a β3
chain, αvβ3 and αIIbβ3. While, αIIbβ3 presence is restricted to
platelets and monocytes, αvβ3 is more ubiquitously expressed
[21]. Based on this pattern of expression, astrocyte αvβ3
integrin was considered the likely candidate integrin involved in
interacting with Thy-1. However, experiments demonstrating
that the αv subunit is associated with β3 were required.
Although, the subfamily of RGD-binding integrins (αIIb, α5,
αv, α8, β3, β5, β6 and β8) is promiscuous with respect to ligand
binding, each integrin appears to have specific and non-
redundant functions [22]. In the case of the leukocyte-specific
receptors, even promiscuity between species has been reported.
For instance, pig ICAM-1 and ICAM-2 bind to human αLβ2
integrin [23]. Additionally, αXβ2 integrin binds equally well to
both human and mouse Thy-1 [18].
To unravel remaining open questions concerning Thy-1-
integrin interaction, we characterized in detail the interaction
between Thy-1 and its astrocytic integrin binding partner.
Immunoprecipitation experiments revealed that the αvβ3
integrin heterodimer is indeed expressed in DI TNC1 astrocytes
and both integrin subunits are required in Thy-1-induced focal
adhesion formation in astrocytes. Importantly, Thy-1 on the
surface of neuronal cathecolaminergic CAD cells specifically
associated with αvβ3 integrin and stimulated astrocytes via a
ROCK-dependent signaling pathway. Although antibodies to
Thy-1 blocked stimulation, binding between neurons and
astrocytes was only partially reduced. Additionally, surface
plasmon resonance analysis using murine and human Thy-1-Fc
recombinant proteins indicated that Thy-1 binds directly to
human αVβ3 integrin. Furthermore, this study shows that the
Thy-1/integrin interaction depended on a) the integrin-binding
RLD motif present in Thy-1 molecule, b) the divalent cations
Mg2+ or Mn2+ but not Ca2+ or the Ca2+/Mg2+ mix and c) that it
was species independent, at least in vitro.2. Materials and methods
2.1. Cells, antibodies and reagents
The rat astrocytic cell line DI TNC1 (ATCC CRL-2005) was maintained in
RPMI medium 1640 (GIBCO) containing 5% serum (FBS, HyClone), 0.1 mM
2-mercaptoethanol (GIBCO) and 100 U/ml penicillin/100 µg/ml streptomycin
(PS mixture, GIBCO). The mouse catecholaminergic neuronal cell line CAD
[24] was maintained in DMEM-F12 (GIBCO) containing 8% FBS and PS
mixture. Other cells used were rat neuron-like cell line PC12 (ATCC CRL-
1721), human embryonic kidney 293 and 293T cells (HEK293, ATCC CRL-
1573; HEK293T, ATCC CRL-11268) grown according to ATCC guidelines. All
cells were maintained in a humidified atmosphere of 5% CO2 at 37 °C.
The mouse recombinant proteins Thy-1(RLD)-Fc, Thy-1(RLE)-Fc and
human TRAIL-R2-Fc were obtained as previously reported [8] and coupled to
Protein-A Sepharose beads (Sigma) for cell stimulation. The RGD-containing
proteins (Kis RGD-GFP, Kis RGE-GFP, Kis peptide, described elsewhere [8])
and the cDNAs for αV and β3 integrin were provided by Dr. Curzio Rüegg
(ISREC, Switzerland). RLD peptide was obtained as described [8]. Polystyrene
microspheres (polybeads) were from PolyScience, Inc (Pensylvania, PA). The
Rho-kinase (ROCK) inhibitor Y-27632 was from Calbiochem (Merck).
Rhodamine-conjugated phalloidin (Sigma) and the antibodies mouse anti-
paxillin mAb (Transduction Laboratories), mouse anti-vinculin mAb (Sigma)
and goat anti-mouse IgG-Alexa Fluor 488 pAb (Molecular Probes) were used in
immunofluorescence experiments. The antibodies used in Western blotting
experiments were horseradish peroxidase (HRP)-coupled goat anti-human IgG
(Sigma), rabbit anti-Thy-1 (Serum 2881, made by ProScience against mouse
Thy-1-Fc recombinant protein and characterized by Western blot analysis using
extracts from different Thy-1+ cell lines, Fig. 1S, see Supplementary Material),
anti-β3 pAb (Santa Cruz) and mouse anti-αV mAb (Transduction Laboratories),
goat anti-rabbit IgG-HRP pAb (Bio-Rad) and goat anti-mouse IgG-HRP pAb
(Sigma). Secondary antibody binding was visualized using the ChemiLucent
Detection System Kit (Chemicon International). The mouse anti-rat β3 integrin
mAb (clone F11, Beckton & Dickinson) was used in immunoprecipitation
experiments. Non-permeable Sulfo-NHS-biotin employed to biotinylate cells
and the BCA reagent used to determine protein concentrations were obtained
from Pierce Chemical Co. All other reagents used were from Sigma or of the
highest grade available. For inhibition of cell–cell interaction or astrocyte
stimulation, antibodies used were: mouse anti-rat β3 integrin mAb (clone F11,
Beckton & Dickinson), mouse anti-αV mAb (Transduction Laboratories),
hamster anti-β1 integrin mAb (clone Ha2/5, Beckton & Dickinson), rat anti-
Thy-1 mAb (clone V8 [25]). Anti- thymic-shared antigen-1 (TSA-1/Sca2) mAb
MTS-35 was employed as a control antibody [26].
2.2. Preparation of recombinant proteins
The human Thy-1 cDNA, obtained by PCR amplification of EST clones
flanked by HindIII and SalI sites, was subcloned into the Fc expression vector as
reported [27]. Recombinant RLD (wild type) and RLE (mutant) human Thy-1-
Fc proteins were purified from culture supernatants of stably transfected
HEK293 cells using high-trap Protein-A-Sepharose columns (GE Healthcare) as
previously reported for mouse Thy-1-Fc proteins [8]. Characterization of these
proteins by Western blotting revealed that all these Thy-1-Fc fusion proteins
were recognized as a single band of the expected molecular mass by anti-human
IgG and anti-Thy-1 antibodies (Fig. 2S, see Supplementary Material).
The cDNA encoding for the extracellular domain of human β3 integrin was
amplified by PCR and cloned into the pCR3 expression vector for Fc fusion
proteins using BamHI and SalI sites available in the primers. The construct for
β3-Fc integrin contains the signal peptide of the Ig heavy chain
(MNFGFSLIFLVLVLKGVQCEV), the sequence KLVPRGS, amino acids
27–718 of human β3 integrin, amino acids VD and the hinge, CH2 and CH3
domains of human IgG1. The cDNA encoding for the extracellular domain of αV
integrin (amino acids 1–994) preceded by a consensus Kozak sequence
(GCCACC) was amplified by PCR and cloned into the Fc expression vector
using the BamHI and SalI sites as described for the β3 integrin. The αVβ3-Fc
fusion protein was expressed in HEK293Tcells by transient co-transfection with
equal amounts of both integrin-Fc expression plasmids. Transfected cells were
grown in serum-free medium (Opti-MEM) for 5 days and the culture supernatant,
Fig. 1. αv integrin dimerized with β3 integrin in rat astrocytes. A) Surface
biotinylated proteins were immunoprecipitated (IPP) with anti-β3 integrin mAb.
Labelled proteins from astrocyte lysates and IPP proteins were revealed with
streptavidin-HRP. B) and C) Proteins in a whole cell lysate were precipitated
with anti-β3 mAb or a control IgG. IPP complexes were separated by SDS-
PAGE in parallel with astrocyte lysate. Proteins transferred to nitrocellulose
were revealed with anti-αv mAb (B) and anti-β3 pAb (C). Values for molecular
mass in kDa are shown to the left of each panel.
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(Amicon). Control supernatants were obtained growing non-transfected HEK293T
cells in Opti-MEM for 5 days and concentrating them as indicated. Recombinant
proteins were characterized by molecular mass determination and on immunoblots
using specific antibodieswhich revealed the presence ofαV,β3 and Fc peptides of the
calculated molecular mass (Fig. 3S-A, see Supplementary Material). αVβ3-Fc
functionality was tested using an enzyme-linked immunosorbent assay (ELISA) and
the protein showed to bind to fibronectin and to different recombinant RGD
containing snake venom peptides (Kis RGD-GFP, Kis peptide) whereas it did not
bind to Kis RGE-GFP (Fig. 3S-B, see Supplementary Material).
2.3. Western blots and immunoprecipitations
Whole cell lysates were obtained from rat DI TNC1 astrocytes in ice-cold-
lysis buffer as described [7]. Protein extracts (50 µg/lane) or immunoprecipitated
proteins were separated by SDS-PAGE (10% gels) and transferred to
nitrocellulose. Membranes were blocked with 5% fat-free milk or 5% gelatin
(for goat antibodies) and then incubated with goat anti-β3 pAb or mouse anti-αV
mAb followed by a second antibody coupled to HRP. The peroxidase activity
was revealed by enhanced chemiluminescence.
For immunoprecipitation, the lysates were clarified by centrifugation and pre-
cleared with Protein A-Sepharose beads for 30 min. Afterwards, pre-cleared
protein extracts were incubatedwith 1–2 µg of anti-β3 integrinmAb or control IgG
coupled to Protein A-Sepharose beads during 1 h at 4 °C. In a different experiment,
cells were first surface biotinylated using non-permeable NHS-biotin (according to
manufacturer's instructions) prior to preparing the lysates, and proteins were
immunoprecipitated as indicated above. Proteins bound to the Ab-coupled beads
were solubilized in Laemmli buffer and processed for immunoblotting. In the case
of biotinylated proteins, nitrocellulose membranes were blocked with 2% BSA in
PBS and then incubated for 1 h with streptavidin-HRP.
2.4. Cell–cell adhesion assay
The relevance of Thy-1-integrin binding in interactions between neurons and
astrocytes was assessed as described [8]. In brief, PC12 cells were labelled with
the CellTracker (Molecular probes) CMTMR red following the manufacturer's
instructions. Once labelled, cells were added to a monolayer of astrocytes in a
24-well plate for 20 min at 37 °C and then gently washed with PBS to remove
unbound cells. Bound neuronal cells were counted with an inverted microscope
equipped with epifluorescence. To interfere with the cellular interaction,
astrocytes were pretreated as reported [8] with soluble chimeric Thy-1-Fc
proteins, anti-αVor anti-β3 integrin antibodies. TRAIL-R2-Fc or anti-β1 integrin
antibodies were used as the respective controls.
2.5. Cell–cell stimulation assay
Astrocytes were seeded on coverslips in 24-well plates and grown for 24 h to
70–80% confluency. Then, cells were washed in serum-free medium and CAD
cells (106 cells/well) were added in the same medium to stimulate focal adhesion
formation for 10 min. Upon simulation, cells were washed twice and then fixed
for indirect immunofluorescence. To test specificity of the interaction, CAD
cells were pre-treated with hybridoma supernatants of anti-Thy-1 mAbs (V8
clone) for 30 min to block Thy-1 on the cell surface. Cells were rinsed twice with
serum-free medium to remove excess of antibody and serum, prior to their
addition to the astrocytes. Alternatively, CAD cells were treated with a
hybridoma supernatant containing a control antibody (MTS-35). To identify
signaling mechanisms involved in the astrocyte response to Thy-1, astrocytes
were pre-treated with the ROCK inhibitor Y-27632 (10 µM) for 30 min at 37 °C
prior to stimulation with CAD cells.
2.6. Indirect immunofluorescence
Astrocytes were stimulated for 10 min with CAD cells and the formation of
focal adhesions and stress fibers were evaluated as reported [20]. To test whether
integrin engagement was sufficient to stimulate focal adhesion formation,
astrocytes were also incubated with 10 µm microspheres coated with RLD
peptide. Polybead microspheres were prepared by incubating 1×106 polybeadswith 4 µg of either RLD, Thy-1-Fc or TRAIL-R2-Fc. After eliminating excess
peptide and washing with PBS, remaining polybead binding sites were blocked
by incubating with 2% fatty acid-free BSA for 60 min. Then, peptide-coated
polybeads were washed again twice with PBS and once with serum-free
medium. Finally, polybeads were added to astrocytes for 10 min. Focal
adhesions were stained with anti-paxillin or anti-vinculin mAbs followed by
anti-mouse IgG-Alexa Fluor 488. Stress fibers were visualized with Rhodamine-
conjugated phalloidin that binds to F-actin. Samples were examined with a Carl
Zeiss Axiovert-135M confocal microscope (LSM Microsystems) following
excitation at 488 or 543 nm. Optical sections obtained and acquired image
z-stacks were processed with Imaris software (Bitplane AG, Zuerich, Switzer-
land). The number of focal adhesions per cell was quantified as previously
described [20].
2.7. Surface plasmon resonance analysis
Protein–protein interaction studies were carried out using a Biacore X
(Biacore, Uppsala, Sweden) as previously described [18]. Wild type (RLD) and
mutated (RLE) Thy-1-Fc proteins of human or mouse origin, or BSA as a
control were covalently immobilized on the carboxy methyl dextran surface of
CM5 chips via primary amino groups, using the amine coupling kit. For all
biosensor assays, HBS was employed as running buffer [10 mM HEPES,
150 mM sodium chloride, (pH 7.4)] containing 1 mM MgCl2 or other divalent
cation.
Human αVβ3-Fc from a concentrated culture supernatant diluted in HBS
buffer as indicated in Fig. 6, were run over the sensor chip at 30 μl/min, 25 °C.
The effect of divalent cations, all at 1 mMwas tested. To repeat the experiments,
CM5 chips were regenerated using 5 mM EDTA as described [18].
2.8. Statistical Analysis
Where appropriate, experimental data were compared to control conditions
using non-parametric statistical analysis for unpaired samples (Mann–Whitney
U Test).
3. Results
Two different approaches were used to demonstrate that the αv
subunit heterodimerizeswithβ3 integrin in astrocytes. Cell surface
proteins were biotinylated and subsequently immunoprecipitated
Fig. 3. Mouse CAD cells stimulated focal adhesion and stress fiber formation in
rat astrocytes in a Thy-1-dependent manner. Astrocytes were washed with
serum-free medium and left as is (A) or stimulated with CAD cells (B). Utilized
CAD cells were either not treated or previously treated with hybridoma
supernatant containing anti-Thy-1 mAb (clone V8) or a control antibody (MTS-
35) for 30 min. After 10 min incubation with CAD cells, astrocytes were gently
washed, fixed and permeabilized for immunofluorescence analysis. Focal
adhesions were stained with anti-vinculin antibodies followed by anti-mouse
IgG-Alexa 488 (green). Stress fibers were marked with Rhodamine-labelled
phalloidin (red). White arrowheads indicate CAD cells bound to astrocytes (B).
The graph (C) shows the quantification of focal adhesions per cell (white bars),
as well as the average area/focal adhesion (black bars). CAD cells stimulated the
formation of more and larger focal adhesions. This effect was inhibited by V8
but not by MTS-35 antibodies (C). CAD cells also stimulated the formation of
stress fibers (B compared to A). Results shown are representative of 3 individual
experiments performed in duplicates. ⁎, pb0.05 with respect to the control non-
treated (NT) cells. #, pb0.05 compared to CAD-stimulated (CAD) cells. Bar in
A is 10 µm.
Fig. 2. Rat PC12 cell binding to DI TNC1 astrocytes involved Thy-1/αvβ3
integrin interaction. Fluorescently labelled, live PC12 cells were incubated over
a monolayer of DI TNC1 astrocytes. In A) astrocytes in a 24-well plate were
treated with 50,100, 300 and 600 ng of recombinant Thy-1-Fc proteins of human
or mouse origin prior to incubation with labelled PC12 cells. TRAIL-R2-Fc
recombinant protein was used as a negative control at 600 ng. In B) astrocytes
were treated with 5 or 10 µg of different anti-integrin antibodies as indicated, for
30 min, before the addition of labelled PC12 cells. Treatment with anti-β1
integrin antibody was used as a negative control in this case. PC12 cells were
then incubated for 20 min with astrocytes, and subsequently washed gently.
Bound labelled cells were counted using an inverted microscope equipped with
epifluorescence. Values shown correspond to the percentage of PC12 cells
bound to astrocytes whereby non-treated cells (NT) were assigned the value
100%. Averages±SE of 3 independent experiments are shown. ⁎, pb0.05
compared to TRAIL-R2-Fc (A) or to anti-β1 integrin (B) treated cells.
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likely corresponding to αv and β3, respectively (Fig. 1A). To
demonstrate that the 120 kDa protein associated with the β3
subunit wasαv integrin, and also that the band of lowermolecular
weight was indeed β3 integrin, non-biotinylated lysates were
immunoprecipitated with either anti-β3 mAb or a control IgG.
Complexes obtained were analyzed by immunoblotting with the
anti-αv antibody (Fig. 1B) and a polyclonal anti-β3 antibody
(Fig. 1C). Bands corresponding to αv (Fig. 1B, 120 kDa band)
and β3 (Fig. 1C, 65 kDa band), were readily observed when the
anti-β3 mAb was employed to immunoprecipitate the integrin
heterodimer. Neither αv or β3 integrins were detected in control
immunoprecipitations with an unrelated IgG (Fig. 1B, C). Thus,
theαvβ3 integrin heterodimer was present at the cell surface of DI
TNC1 astrocytes although the β3 integrin identified was smaller
than anticipated.
To test whether the αvβ3 integrin heterodimer was required
for neuron–astrocyte association, a previously described cell–
cell adhesion assay was employed [8]. Furthermore, Thy-1
interaction with β3-containing integrin has been demonstrated
between either EL-4 thymoma cells or Thy-1-Fc recombinantprotein and astrocytes. Thus, this assay was employed to
demonstrate that Thy-1-integrin binding participated in neu-
ron–astrocyte interaction as well. Indeed, binding of rat PC12
cells to a monolayer of rat DI TNC1 astrocytes was detected.
This interaction was inhibited, in a dose-dependent manner, by
pretreatment with either human or mouse Thy-1-Fc proteins
(Fig. 2A). As expected, pre-treatment with either anti-αv or anti-
β3 integrin antibodies reduced significantly cell–cell interaction
detected by this assay (Fig. 2B), whereas no effect was observed
upon pre-incubation with equivalent amounts of TRAIL-R2-Fc
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negative controls. In this context, it is important to note that
expression of β1 integrin and presence at the cell surface were
verified by immunoblotting and flow cytometric analysis,
respectively, using the same antibody (data not shown). Thus,
the rat PC12 bound to rat DI TNC1 cells and this association
was diminished by Thy-1-Fc recombinant proteins. Addition-
ally, given that not only anti-β3 integrin antibody but also anti-
αv antibody reduced the level of interaction, these results
indicate that neuron–astrocyte association in this in vitro assay
is dependent to a considerable extent on Thy-1-αvβ3 integrin
interaction.
A second cell line (CAD cells) of mouse origin was used to
test whether neuronal cells not only bind to, but additionally
stimulate a response in rat DI TNC1 astrocytes. As shown in
Fig. 3B, the formation of substantially larger focal adhesions
(green/yellow dots) was observed in astrocytes exposed to CAD
cells (arrowheads) than in non-stimulated astrocytes (Fig. 3A).
Quantification of the number of focal adhesions per cell and of
the average area per focal adhesion showed that CAD cellsFig. 4. The formation of focal adhesions but not neuron–astrocyte interaction per se
with serum-free medium and stimulated with CAD cells either not treated (A and C
(B and D) as indicated in Fig. 3. After 10 min of neuron–astrocyte incubation, cells w
adhesions (green) and F-actin (red). White arrowheads indicate CAD cells bound to a
show cells in the xz plane (A′ and B′) and xy plane (A″ and B″). Blue bars mark the a
and A″ green/yellow dots corresponding to focal adhesions are apparent in the area of
are detectable in the area of contact. C and D correspond to the same fields shown
projections obtained using Imaris software (Bitplane AG, Zurich, Switzerland) to sho
stress fiber formation only when Thy-1 was available (C) and not in the presence o
experiments performed in duplicates. Magnification bar is 10 µm.stimulated both the formation of additional and larger focal
adhesions in astrocytes (Fig. 3C). Such increased adhesion was
inhibited by an anti-Thy-1 (clone V8) monoclonal antibody but
not by a control antibody (Fig. 3C; see also Fig. 4). Other
controls included treatment of astrocytes for the same period of
time (10 min) with conditioned medium from CAD cells or
conditioned medium obtained from co-cultures of CAD-DI
TNC1 cells. None of these media had an effect on the formation
of focal adhesions and stress fibers in astrocytes (data not
shown), suggesting that the astrocytic response to CAD cells is
not caused by soluble factors but rather by the direct interaction
of these two cell types.
Staining of polymerized actin with rhodamine-labelled
phalloidin permitted visualization of CAD cells adhering to the
astrocyte monolayer (white arrowheads in Figs. 3B and 4). This
becomes more apparent when optical sections obtained in the
z-axis are projected in three dimensions as shown in Fig. 4C and
D. Orthogonal sections of the same images showing the xz-plane
(Fig. 4A′) and xy-plane (Fig. 4A″) indicated that focal adhesions
were exclusively detected in astrocytes and were enriched in thewas completely dependent on Thy-1-integrin binding. Astrocytes were washed
) or treated with hybridoma supernatant containing anti-Thy-1 mAb (clone V8)
ere gently washed and then prepared for immunofluorescence analysis of focal
monolayer of astrocytes. These are easier to observe in orthogonal sections that
rea where CAD cells (round cells) were bound to the astrocyte monolayer. In A′
cell–cell contact. In B′ and B″, on the other hand, very few and small focal points
in A and B, respectively. However here, z-stack-sections are visualized in 3D
w that CAD cells bound to the astrocyte monolayer induced focal adhesion and
f an anti-Thy-1 antibody (D). Results shown are representative of 3 individual
Fig. 6. Mouse and human Thy-1-Fc wild type proteins directly interacted with
human αvβ3-Fc recombinant protein in a cation-dependent manner. Concen-
trated supernatant from the cells expressing αvβ3-Fc was diluted sequentially
(1/50–1/400) in Hepes buffer saline (HBS) containing 1 mM MgCl2.
Concentrated supernatant from non-transfected HEK293T cells diluted 1/50 in
the sameHBSbufferwas used as a control (Con 1/50). A)HumanThy-1(RLD)-Fc,
B) humanThy-1(RLE)-Fc, C) andD)mouseThy-1(RLD)-Fcwere immobilized on
CM5chips. Concentrated supernatantswere diluted asmentioned (or 1/400 inD) in
HBS buffer containing 1 mM MgCl2 or other cations as indicated (all at 1 mM).
EDTA (5 mM) was used as a control. Binding of αvβ3-Fc was monitored at
different time points and the binding was expressed in Response Units (RU). Data
shown are representative of at least 3 independent experiments.
Fig. 5. Effects of ROCK inhibition and RLD-coated polybeads in astrocytes.
A. Astrocytes seeded on coverslips in 24-well plates were washed with serum-
free medium and treated or not for 30 min with Y-27632 (10 µM) prior to
stimulating with CAD cells, as indicated in Fig. 3. After 10 min in the presence
of CAD cells, DI TNC1 cells were gently washed and then prepared for
immunofluorescence analysis of focal adhesions. Data show the number of focal
adhesions per cell (white bars), as well as the average area/focal adhesion (black
bars). The presence of CAD cells increased size and number of focal adhesions in
DI TNC1 cells, but had no effect when astrocytes were pre-treated with Y-27632.
Values are averages±SD from 2 different experiments. B. DI TNC1 cells left
overnight to adhere to coverslips were washed with serum-free medium and
treated with polybeads coated with fatty acid-free BSA, Thy-1-Fc, RLD peptide
or TRAIL-R2-Fc. Focal adhesions were quantified after stimulating with coated-
polybeads for 10 min and preparing the cells for immunofluorescence as
indicated in Fig. 3. Results are representative of 3 independent experiments.
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Fig. 4A′ and 4A″). This effect was not detectable whenCAD cells
were pre-treated with the monoclonal anti-Thy-1 antibody
(compare areas indicated by the blue bar in Figs. 4B′, 4B″ with
4A′, 4A″; see also Fig. 3C for data quantification), whereas a
control antibody (clone MTS-35) had no effect (Fig. 3C).
Interestingly, despite the ability of the anti-Thy-1 antibody to
block signaling events linked to focal adhesion formation, CAD
cell–astrocyte binding was still detectable (see also Fig. 2A and
B). This most likely reflects the participation of additional cell
adhesion molecules in neuron–astrocyte interaction (white
arrowheads in Fig. 4B and D). These results underscore the
importance of Thy-1-integrin binding both in neuron–astrocyte
association and communication.
Recombinant Thy-1-Fc fusion protein induces focal adhe-
sion and stress fiber formation via integrin-mediated phosphor-ylation of FAK and p130Cas, the recruitment of vinculin,
paxillin and FAK to focal adhesion sites and further activation
of RhoA and ROCK [8,19,20]. To assess whether CAD cells
activate signaling pathways similar to those detected with Thy-1
alone, a ROCK inhibitor was employed. Indeed, in astrocytes
pre-treated with the Y-27632 compound, no increase in the
formation of focal adhesions was observed following stimula-
tion with CAD cells. Furthermore, in this case, focal adhesions
were less abundant than those observed for non-stimulated
astrocytes (Fig. 5A).
Fig. 7. Mouse and human Thy-1-Fc wild type proteins stimulated focal adhesion
and stress fiber formation in rat astrocytes. Astrocytes either not treated (A) or
treated for 10minwith Protein-ASepharose beads containing TRAIL-R2-Fc (B),
mouse Thy-1(RLE)-Fc (C), mouse Thy-1(RLD)-Fc (D), human Thy-1(RLE)-Fc
(E) or human Thy-1(RLD)-Fc (F) were fixed, permeabilized and stained for focal
adhesions with anti-paxillin mAb (green) and stress fibers with Rhodamine-
coupled phalloidin (red). G) Number of focal adhesions/cell (white bars), as well
as the average area/focal adhesion (black bars) were quantified using Image
J software from the NIH public domain. Only mouse and human Thy-1(RLD)-Fc
significantly stimulated the formation of new and larger focal adhesions. Images
are representative of results obtained in at least 3 different experiments.
⁎, pb0.05 with respect to the control non-treated (NT) cells. #, pb0.05 compared
to the values obtained when stimulating with the respective mouse or human
RLD protein. Magnification bar is 20 µm.
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sufficient to stimulate astrocytes, Thy-1-Fc- or RLD-coated
microspheres were added to astrocytes. A two-fold increase in
focal adhesion number and area was observed in both cases,
whereas, no effect was detected in cells treated with control
TRAIL-R2-Fc-coated microspheres or microspheres alone
(Fig. 5B).
To evaluate whether the interaction between αvβ3 and Thy-1
proteins was direct, surface plasmon resonance (SPR) analysis
was utilized. Human αvβ3-Fc, as well as human and murine
Thy-1-Fc recombinant proteins, were obtained and character-
ized as indicated in Materials and methods. Recombinant αvβ3-
Fc protein containing only the extracellular domains of the
integrin subunits was obtained by co-expressing both αv-Fc and
β3-Fc in HEK293T cells. Soluble recombinant integrin was
used in serum-free supernatants, since attempts to purify this
protein resulted in a non-functional integrin. Transiently
transfected HEK293T cells secreted the αvβ3-Fc heterodimer,
however, αv-Fc was not detected when overexpressed in the
absence of β3-Fc and, β3-Fc was not detected in the absence of
αv-Fc (see Fig. 3S-A in Supplementary Material).
αvβ3-Fc bound to both human and mouse Thy-1-Fc proteins
in a concentration-dependent manner (Fig. 6A and C,
respectively), whereas, no interaction was observed with either
the mutated human (Fig. 6B) or mouse Thy-1(RLE)-Fc protein
(not shown). Likewise, no binding was observed with control
supernatants (Fig. 6A–C). These results indicate that αvβ3
integrin and Thy-1 proteins interact directly and that the Thy-1
RLD motif molecule is important for interaction with the
integrin.
Coordination of divalent metal ions induces conformational
changes of integrins that initiate the low- to higher-affinity
transition [21,28]. To study cation-dependence, the interaction
between mouse Thy-1-Fc and αvβ3-Fc was tested by SPR in the
presence of three individual cations, EDTA or a Ca2+/Mg2+ mix.
The observed order of cation preference in the binding assay was
as follows: Mg2+NMn2+NCa2+ =Ca2+/Mg2+ (Fig. 6D). A
similar cation-dependence was observed for the human Thy-1-
Fc protein in that no binding was detected in the presence of
either Ca2+ alone or the Ca2+/Mg2+ mix. Indeed, cation prefer-
ence for binding between the proteins of human origin was
similar to that observed for the mouse proteins (Mn2+NMg2+N
Ca2+=Ca2+/Mg2+, data not shown). In all cases, the presence of
EDTA completely abrogated binding indicating the critical role
of specific divalent cations in this interaction. Similar cation
requirements have previously been reported for αvβ3 integrin
activation in cells [29].
These experiments also suggested that the interaction was
not species-specific, at least in vitro. However, absence of
specificity may have been due to the fact that these fusion
proteins were all produced by HEK293 or HEK293T cells.
Thus, to characterize species-specificity further, Thy-1-Fc
proteins were used to trigger a cellular response in rat DI
TNC1 astrocytes. Mouse wild type (RLD) Thy-1-Fc protein
was previously shown to stimulate focal adhesion and stress
fiber formation, while the mutated (RLE) form did not
[8,19,20]. These results were confirmed here: mouse Thy-1(RLD)-Fc protein induced focal adhesion and stress fiber
formation (Fig. 7D). Alternatively, for astrocytes treated with
either mouse Thy-1(RLE)-Fc protein (Fig. 7C) or TRAIL-R2-Fc
used as a control (Fig. 7B), focal adhesions were similar to those
in non-stimulated cells (Fig. 7A). In addition, results obtained
here employing human Thy-1-Fc proteins indicated that the wild
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tion of focal adhesions and stress fibers (Fig. 7F), while the
mutated Thy-1(RLE)-Fc had no effect on the rat astrocytic cell
line (Fig. 7E). Thus, Thy-1-elicited effects in astrocytes
required the RLD motif and were species-independent.
Taken together, these data indicate that a) αvβ3 integrin is a
receptor for Thy-1, b) neurons induce focal adhesion formation
in astrocytes only if neuronal Thy-1 engages αvβ3 integrin in
astrocytes, c) αvβ3 integrin binds directly to Thy-1 in a manner
that depends on the presence of the Thy-1 RLD motif and
divalent cations (Mg2+ and Mn2+ but not Ca2+), d) neuron–
astrocyte association mediated by Thy-1-integrin interaction
triggers focal adhesion and stress fiber formation via a signaling
pathway that involves ROCK activation, and e) these interac-
tions are not species-specific, at least in vitro and in situ in cells.
4. Discussion
The abundantly expressed neuronal glycoprotein Thy-1
binds to a β3 integrin on astrocytes and triggers the formation
of focal contact sites [8]. In the present study, upon verifying the
presence of the αvβ3 integrin heterodimer on these astrocytes
(Fig. 1), the requirement of both subunits for neuron–astrocyte
interaction was demonstrated in a cell-binding assay (Fig. 2).
Most importantly, the mouse CAD cell line stimulated focal
adhesion formation in astrocytes in a Thy-1-dependent manner
but interacted with astrocytes even when Thy-1-integrin
binding was blocked with antibodies (Figs. 3 and 4). Signaling
triggered by Thy-1 required the RLD motif to engage integrins
and involved downstream activation of ROCK in astrocytes,
since the inhibition of this kinase by a specific inhibitor
precluded CAD cell stimulated focal adhesion formation
(Fig. 5). Furthermore, we expressed recombinant, soluble and
functional αvβ3 integrin and showed by SPR analysis that Thy-1
binding was direct and required Mg2+ or Mn2+ but was not
species-specific (Fig. 6). Additionally, no species specificity was
detected in cellular assays evaluating responses in rat astrocytes
induced by human and mouse Thy-1-Fc proteins (Fig. 7) or
using a mouse neuronal cell line (Figs. 3 and 4).
Expression of β3 integrin subunits on the surface of DI
TNC1 astrocytes had been previously determined by our
laboratory using flow cytometry. However, due to the
unavailability of anti-rat αv integrin antibodies at the time, the
presence and participation of this subunit in Thy-1-induced
astrocyte responses could not be confirmed [8]. The unequi-
vocal identification of both integrin subunits in DI TNC1
astrocytes is shown here (Fig. 1). Unexpectedly, the molecular
mass of the β3 subunit was different to that reported for this
integrin, while that observed for the αv integrin of approxi-
mately 120 kDa is in agreement with previous studies [30].
Monoclonal and polyclonal antibodies from two different
sources recognized the same 65 kDa protein by immunopreci-
pitation and immunoblotting, respectively. Cell surface bioti-
nylation indicated that the β3 subunit possessed an extracellular
domain and the assays using cells [immunofluorescence for
focal contact identification (Fig. 7), as well as cell–cell adhesion
and stimulation assays (Figs. 2–5)] pointed towards thepresence of a functionally active αvβ3 heterodimer in DI
TNC1 astrocytes. Heterogeneity of αvβ3 integrin obtained from
different tissues is generally attributed to alternative mRNA
splicing [31–33]. Alternatively, proteolytic cleavage has also
been reported [34]. Thus, a possible explanation for these
results is that astrocytes express an as yet unidentified β3 variant
or that β3 integrin in these cells is sensitive to protease
degradation after cell lysis.
Thy-1-αvβ3 integrin binding is one of many interactions
mediating adhesion between neurons and astrocytes. Accord-
ingly, antibodies or fusion proteins that bound to either Thy-1 or
the integrin never blocked cell–cell adhesion completely ([8]
and Fig. 2). Interestingly, an anti-Thy-1 antibody that bound to
the surface of CAD cells blocked the Thy-1-induced signaling
response in astrocytes. However, CAD cells were still able to
bind to astrocytes (Fig. 4B and D), albeit less efficiently (data
not shown). Importantly, unlike wild type thymoma cells (EL-
4), cells deficient in synthesis of the GPI anchor (EL4−f), which
lack Thy-1 on their surface, also adhere less to astrocytes and do
not trigger morphological changes in these cells [8]. These
results highlight the selective ability of Thy-1 to trigger focal
adhesion and stress fiber formation as a consequence of integrin
binding during neuron–astrocyte association.
Signaling events involved in neuronal stimulation of
astrocytes via Thy-1-αvβ3 integrin interaction are likely to
include FAK and p130Cas tyrosine phosphorylation, as well as
activation of Rho and ROCK to induce focal adhesion and stress
fiber formation. This sequence of events was previously reported
for astrocytes stimulated with recombinant Thy-1-Fc [8,19,20],
and is infered here, since the specific ROCK inhibitor Y-27632
precludes astrocyte stimulation by CAD cells.
Since Thy-1 in neurons has been implicated in the inhibition
of neurite extension [6], the possibility that signaling events in
astrocytes triggered by neuronal Thy-1 may also play a role in
axonal growth is intriguing. Therefore, Thy-1-αvβ3 integrin
interaction could act bimodaly inducing morphological changes
in astrocytes and, at the same time, triggering signals to neurons
via Thy-1. The availability of a functional αvβ3-Fc recombinant
protein is an invaluable tool that we are at present employing to
test this possibility.
Truncated αvβ3 has been previously expressed and purified
in a baculovirus system and proven to be functional by ligand-
recognition experiments [35]. Here, the co-expression of human
αv-Fc and β3-Fc also generated a functional heterodimer with
binding capacity for its RGD-containing ligands (see Fig. 3S-B
in Supplemantary Material) and for Thy-1 of human and mouse
origin by SPR analysis (Fig. 6). Interestingly, αv-Fc was not
secreted in the absence of β3-Fc and vice-versa, in agreement
with existing evidence demonstrating that uncomplexed α or β
subunits remain trapped in the endoplasmic reticulum [36,37].
SPR, a sensitive tool to study specific binding events such as
protein–protein interactions, was employed here to demonstrate
direct interaction between Thy-1-Fc and αvβ3-Fc integrin. None
of the mutated Thy-1(RLE)-Fc proteins bound integrin by
this method. Additionally, these studies revealed that Mg2+ and
Mn2+ but neither Ca2+ or Ca2+/Mg2+ promoted Thy-1/integrin
interaction (Fig. 6). These results are in agreement with our
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motif and of divalent cations for the interaction [8,19].
Additionally, results presented here indicate that the RLD
peptide alone attached to polybeads induces focal adhesion
formation to the same extent as Thy-1-Fc-polybeads, likely
indicating that the RLD motif is sufficient to trigger the
response by integrin engagement. However, given that cells
treated with the RLD-polybeads were adherent (bound to
extracellular matrix), contributions from different ligand-
receptor interactions cannot be ruled out.
The RLD tripeptide of Thy-1 is present in a highly conserved
region of the glycoprotein. Indeed, Thy-1 of human, rat and
mouse origin share roughly 70% homology in the amino acid
sequence flanking the RLD region (10aa in each direction), as
estimated using the program for multiple sequence alignment
Clustal W [38]. Moreover, Thy-1 N-glycosylation is known
to be highly conserved [39]. Thus, it is unlikely that the
N-glycosylation site located close to the RLD segment confers
diversity to this region. Since integrin-Thy-1 interaction re-
quires this tripeptide, and integrins are reportedly promiscuous
with respect to ligand recognition (Reviewed by [22]), the lack
of species-specificity shown to occur here between isolated
proteins (Fig. 6) and cells (Figs. 3 and 4) is not surprising. Our
previous report showing binding between a mouse thymoma
cell line and rat astrocytes [8], already suggested this lack of
species-specificity which is corroborated here using isolated
recombinant proteins and cells of different origin. The pref-
erence of Thy-1 for particular integrins, such as αvβ3 and αXβ2
integrins [8,18] is likely due to the presence of an RLD motif
instead of the more typical RGD integrin-binding site (Reviewed
by [40]).
Brain injury leads to astrogliosis, a process that involves the
activation of astrocytes which increase in size and migrate to the
damaged site to form the glial scar. This structure strongly
inhibits regeneration in the central nervous system (Reviewed
by [41]) in part as the consequence of a change in the profile of
protein expression whereby the number of proteins that inhibit
axonal regeneration increases [42]. Morphological changes
observed in reactive astrocytes in vivo may be related to those
triggered by Thy-1 in astrocytes in culture, which occur very
rapidly via integrin clustering and activation of RhoA [20].
Interestingly, αvβ3 integrin is reportedly absent in astrocytes
obtained from postnatal and adult rat brains [43,44]; however,
following an ischemic insult to the central nervous system, αvβ3
integrin expression increases in astrocytes of the peri-infarct
region [45]. Additionally, our own data suggest that cytokines, a
stimulus that triggers astrogliosis [41], induce the expression of
β3 integrin in neonatal rat primary astrocytes (Herrera-Molina
and Leyton, unpublished results). Therefore, if integrin up-
regulation occurs upon brain damage, subsequent interaction
with the abundantly expressed neuronal Thy-1 protein could
lead to both morphological changes in astrocytes and inhibition
of axonal regeneration.
In summary, the Thy-1-αvβ3 integrin interaction character-
ized here contributes to a better understanding of fundamental
aspects of astrocyte/neuron interaction. Furthermore, since
this interaction involves two cell adhesion molecules that arenot only expressed in the brain, the observations reported
here are likely to be relevant to other physiopathological sit-
uations where these proteins are implicated, including mela-
noma metastasis [16], leukocyte recruitment and extravasation
[15,18].
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